Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,852,365
+$2,935,404 QoQ
Shares Held
456,761
-10.6% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#77
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,100,351,284 across 114 Biotechnology names. EXEL ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,852,365 | 456,761 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,916,961 | 511,004 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $27,586,908 | 629,407 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,604,378 | 377,830 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,606,134 | 195,239 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,906,136 | 105,800 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,942,249 | 238,506 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,725,574 | 297,710 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,652,869 | 474,093 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $15,634,723 | 658,859 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $18,265,433 | 761,377 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,874,316 | 543,447 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $1,970,336 | 103,105 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,385,446 | 71,378 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $14,360,274 | 895,279 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $13,943,736 | 889,269 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,864,594 | 1,002,142 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $7,337,303 | 323,657 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,241,829 | 177,343 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,519,564 | 71,881 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $486,474 | 26,700 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $729,182 | 32,279 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $521,940 | 26,006 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,990,465 | 408,608 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $10,485,435 | 441,678 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,498,655 | 493,534 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||